Philip L Pasternak, MD | |
911 E County Line Rd, Suite 201, Lakewood, NJ 08701-2069 | |
(732) 254-4000 | |
(732) 901-4337 |
Full Name | Philip L Pasternak |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 31 Years |
Location | 911 E County Line Rd, Lakewood, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093761546 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | MA07657600 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Philip L Pasternak, MD Po Box 67, East Brunswick, NJ 08816-0067 Ph: (732) 254-4000 | Philip L Pasternak, MD 911 E County Line Rd, Suite 201, Lakewood, NJ 08701-2069 Ph: (732) 254-4000 |
News Archive
Testing for cocaine and other drugs usually involves two steps: a quick on-site prescreen, and then a more accurate confirmatory test at a distant laboratory.
The head of Noridian Healthcare Solutions says the HHS inspector general's office sought documents related to the company's work on Maryland's online health insurance marketplace.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand.
› Verified 7 days ago